Arrowhead Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 3,696 | 0.0% | 55,673 | 12/31/2025 |
| 2025 Q3 | 10/22/2025 | 2,276 | 0.0% | 65,999 | 9/30/2025 |
| 2025 Q2 | 8/6/2025 | 921 | 0.0% | 58,310 | 6/30/2025 |
| 2025 Q1 | 5/9/2025 | 425 | 0.0% | 33,364 | 3/31/2025 |
| 2024 Q4 | 2/10/2025 | 644 | 0.0% | 34,266 | 12/31/2024 |
| 2024 Q3 | 10/18/2024 | 670 | 0.0% | 34,588 | 9/30/2024 |
| 2024 Q2 | 7/31/2024 | 901 | 0.0% | 34,663 | 6/30/2024 |
| 2024 Q1 | 4/29/2024 | 956 | 0.0% | 33,413 | 3/31/2024 |
| 2023 Q4 | 2/6/2024 | 1,038 | 0.0% | 33,928 | 12/31/2023 |
| 2023 Q3 | 10/23/2023 | 920 | 0.0% | 34,242 | 9/30/2023 |
| 2023 Q2 | 8/10/2023 | 1,226 | 0.0% | 34,390 | 6/30/2023 |
| 2023 Q1 | 5/11/2023 | 867 | 0.0% | 34,172 | 3/31/2023 |
| 2022 Q4 | 2/7/2023 | 254 | 0.0% | 6,271 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 215 | 0.0% | 6,513 | 9/30/2022 |
| 2022 Q2 | 7/19/2022 | 238 | 0.0% | 6,764 | 6/30/2022 |
| 2022 Q1 | 5/4/2022 | 259 | 0.0% | 5,648 | 3/31/2022 |
| 2021 Q4 | 1/31/2022 | 411 | 0.0% | 6,209 | 12/31/2021 |
| 2021 Q3 | 10/29/2021 | 402 | 0.0% | 6,449 | 9/30/2021 |
| 2021 Q2 | 8/11/2021 | 905 | 0.0% | 10,934 | 6/30/2021 |
| 2021 Q1 | 5/4/2021 | 809 | 0.0% | 12,203 | 3/31/2021 |
| 2020 Q4 | 2/11/2021 | 939 | 0.0% | 12,238 | 12/31/2020 |
| 2020 Q3 | 11/5/2020 | 516 | 0.0% | 12,002 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 516 | 0.0% | 11,968 | 6/30/2020 |
| 2020 Q1 | 5/11/2020 | 335 | 0.0% | 11,665 | 3/31/2020 |
| 2019 Q4 | 2/5/2020 | 871 | 0.0% | 13,740 | 12/31/2019 |